477 Survival analysis of endometrial cancer. our experience in las palmas de gran canaria

Autor: AF Rave Ramirez, A. Martín Martínez, D González García-Cano, O Arencibia Sanchez, L. Molero Sala, M Laseca Modrego
Rok vydání: 2021
Předmět:
Zdroj: Endometrial cancer.
DOI: 10.1136/ijgc-2021-esgo.155
Popis: Introduction/Background* Self-evaluation and analysis of healthcare practice in a Gynecology Oncology unit represents an advance in the strategy to improve the quality of cancer care, in this case,endometrial cancer, allowing to obtain relevant data on the quality of care practice. Methodology Retrospective descriptive study carried out in CHUIMI. We included patients diagnosed with endometrial cancer during the study period 2012-2016. We analyzed epidemiological variables, histological type, type of treatment, final FIGO stage and 5-year overall survival. Result(s)* A total of 498 patients were diagnosed with endometrial cancer during this period. Mean age of 64.3 years (range 29–89 years) and a mean BMI of 33.5. 60.2% of the patients were diagnosed in stage IA; 48.7% of which were grade 1 and 2. Type I (endometrioid and mucinous) accounted for 74.3% versus 25.7% type II. 40.8% of the patients were classified as low risk presenting a 5-year survival of 99%. Patients with intermediate risk represented 5.9% and had a 96% 5-year survival. Patients with intermediate-high risk (19.7%) had a 5-year survival of 88%. The patients included in the high-risk group (28.2%), had a 5-year survival of 62%, these differences were statistically significant. We analyzed survival according to the histological type, finding a 5-year overall survival rate of 91.9% in type I, while it was 60.8% fot type II, these differences were statistically significant. Conclusion* The data analyzed in our Gynecology Oncology Unit are similar to those exposed in the literature, there is an important difference in terms of 5-year survival between the low and high risk groups, 99% vs 62% respectively.
Databáze: OpenAIRE